Breaking News Instant updates and real-time market news.

ATUS

Altice USA

$21.09

-0.15 (-0.71%)

17:55
01/08/18
01/08
17:55
01/08/18
17:55

Altice spin off of Altice USA to occur in 2Q18

The transaction will increase the economic ownership of public stockholders of Altice USA from 10.3% of the total share capital of Altice USA to 42.4%. Assuming 100% of Altice NV public shareholders elect to receive Altice USA Class B Common Stock, the voting percentage of the Altice USA public stockholders will increase from 0.6% to 47.2% and the ATUS Next Concert will have 51.2% of the voting power. Assuming 0% of Altice NV public shareholders elect to receive Altice USA Class B Common Stock, the voting power of the Altice USA public stockholders will increase from 0.6% to 4.7% and the ATUS Next Concert will have 93.7% of the voting power. The separation will require the publication of formal documentation in Europe and an effective registration statement on file with the U.S. SEC in the US and require U.S. regulatory approvals. An EU prospectus is to be filed with the Dutch Authority for the Financial Markets for review and approval. Altice USA has filed a Registration Statement on Form S-1 with respect to the separation with the SEC. Upon approval from the AFM and notification for passporting in relevant Member States of the EU, and declaration by the SEC of the effectiveness of the Registration Statement on Form S-1, the EU prospectus will be made available on the website of Altice NV. The separation was approved by the Altice NV Board of Directors on January 8, 2017, and is subject to Altice NV shareholder approval. An EGM is expected to be held in Q2 2018. The separation will be effected by the distribution in kind of Altice USA shares to shareholders of Altice NV, which is expected to occur in Q2 2018 post EGM approval.

ATUS Altice USA
$21.09

-0.15 (-0.71%)

11/07/17
GSCO
11/07/17
UPGRADE
Target $31
GSCO
Buy
Altice USA upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Brett Feldman upgraded Altice USA to Buy saying the stock's pullback over the past two months has created an attractive entry point. The company now trades at a material discount to peers despite being less exposed to incremental broadband competition, Feldman tells investors in a research note. He lowered his price target for the shares to $31 from $33.
11/10/17
MOFT
11/10/17
UPGRADE
MOFT
Buy
Altice USA upgraded to Buy from Neutral at MoffettNathanson
11/14/17
RBCM
11/14/17
NO CHANGE
Target $35
RBCM
Outperform
Altice USA price target lowered to $35 from $40 at RBC Capital
RBC Capital analyst Jonathan Atkin lowered his price target on Altice USA to $35 but kept his Outperform rating following the company's Q3 earnings miss on November 2nd. Atkin says the subsequent sell-off is driven by operating concerns at the parent company rather than specific challenges for the U.S. unit, adding that the current valuations are attractive.
12/13/17
SOCG
12/13/17
INITIATION
SOCG
Buy
Altice USA initiated with a Buy at Societe Generale

TODAY'S FREE FLY STORIES

TEVA

Teva

$20.90

-0.12 (-0.57%)

11:04
01/23/18
01/23
11:04
01/23/18
11:04
Conference/Events
Morgan Stanley pharmaceuticals analyst holds analyst/industry conference call »

Major & Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$4.37

0.21 (5.05%)

11:04
01/23/18
01/23
11:04
01/23/18
11:04
Periodicals
22nd Century mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSG

Madison Square Garden

$211.04

-0.265 (-0.13%)

11:02
01/23/18
01/23
11:02
01/23/18
11:02
Hot Stocks
Madison Square Garden, ParkWhiz form marketing partnership »

The Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

11:02
01/23/18
01/23
11:02
01/23/18
11:02
Hot Stocks
Obalon Therapeutics down over 9% after reporting whistleblower allegations »

After resuming trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OBLN

Obalon Therapeutics

$5.19

-0.05 (-0.95%)

11:00
01/23/18
01/23
11:00
01/23/18
11:00
Hot Stocks
Breaking Hot Stocks news story on Obalon Therapeutics »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

AKS

AK Steel

$6.15

-0.07 (-1.13%)

11:00
01/23/18
01/23
11:00
01/23/18
11:00
Options
AK Steel calls outpace puts 30:1 »

AK Steel calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

, DIS

Disney

$110.40

-0.7 (-0.63%)

11:00
01/23/18
01/23
11:00
01/23/18
11:00
Hot Stocks
Buckingham breaks from analyst crowd with post-earnings downgrade of Netflix »

Shares of Netflix (NFLX)…

NFLX

Netflix

$227.58

7.12 (3.23%)

DIS

Disney

$110.40

-0.7 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 06

    Feb

ZSAN

Zosano Pharma

$0.47

0.0164 (3.64%)

10:55
01/23/18
01/23
10:55
01/23/18
10:55
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

OSTK

Overstock.com

$77.40

-0.25 (-0.32%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Periodicals
Overstock ICO promotion 'false and misleading,' Medium contributor says »

A contributor to Medium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip.com

$46.14

-0.71 (-1.52%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Options
Short-term put buyers in Ctrip as shares stumble »

Short-term put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

$5.19

-0.05 (-0.95%)

10:46
01/23/18
01/23
10:46
01/23/18
10:46
Hot Stocks
Obalon Therapeutics terminates stock offering after whistleblower allegations »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TFX

Teleflex

$274.20

-0.55 (-0.20%)

10:44
01/23/18
01/23
10:44
01/23/18
10:44
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Medical Devices Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 28

    Feb

  • 01

    Mar

TWTR

Twitter

$22.73

-0.5928 (-2.54%)

10:42
01/23/18
01/23
10:42
01/23/18
10:42
Recommendations
Twitter analyst commentary  »

Twitter data points to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ILG

ILG

$29.45

-0.03 (-0.10%)

10:40
01/23/18
01/23
10:40
01/23/18
10:40
Options
Repeat interest in ILG Mar 30 calls »

Repeat interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
01/23/18
01/23
10:35
01/23/18
10:35
Conference/Events
Morgan Stanley technology analyst holds an analyst/industry conference call »

Technology/Hardware…

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

, JKHY

Jack Henry

$125.32

0.17 (0.14%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

JKHY

Jack Henry

$125.32

0.17 (0.14%)

WWD

Woodward

$81.02

0.52 (0.65%)

NAV

Navistar

$44.96

0.21 (0.47%)

GBT

Global Blood Therapeutics

$56.35

2.4 (4.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

, GPRO

GoPro

$6.30

0.01 (0.16%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

NFLX

Netflix

$227.58

7.12 (3.23%)

GPRO

GoPro

$6.30

0.01 (0.16%)

W

Wayfair

$88.60

-2.04 (-2.25%)

FTNT

Fortinet

$45.85

-0.16 (-0.35%)

S

Sprint

$5.23

-0.091 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 02

    Feb

  • 05

    Feb

  • 22

    Feb

DG

Dollar General

$103.69

1.424 (1.39%)

, DKS

Dick's Sporting

$34.91

0.29 (0.84%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DG

Dollar General

$103.69

1.424 (1.39%)

DKS

Dick's Sporting

$34.91

0.29 (0.84%)

CAT

Caterpillar

$170.43

-0.46 (-0.27%)

RMD

ResMed

$101.77

14.26 (16.30%)

HPE

HP Enterprise

$16.37

0.315 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

SBUX

Starbucks

$61.41

0.15 (0.24%)

10:30
01/23/18
01/23
10:30
01/23/18
10:30
Options
Starbucks calls drawing interest ahead of earnings »

Starbucks calls drawing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

KMB

Kimberly-Clark

$117.35

0.4358 (0.37%)

10:29
01/23/18
01/23
10:29
01/23/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

KMI

Kinder Morgan

$19.45

-0.18 (-0.92%)

10:28
01/23/18
01/23
10:28
01/23/18
10:28
Hot Stocks
Kinder Morgan begins operations of Utopia Pipeline system »

Kinder Morgan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$117.26

0.35 (0.30%)

10:27
01/23/18
01/23
10:27
01/23/18
10:27
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark: China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PFIE

Profire Energy

$2.01

0.03 (1.52%)

10:26
01/23/18
01/23
10:26
01/23/18
10:26
Conference/Events
Profire Energy management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Netflix management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MLHR

Herman Miller

$40.95

0.4 (0.99%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Herman Miller management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 31

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.